Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
106.00
-0.64 (-0.60%)
Jul 16, 2025, 3:29 PM IST
Ind-Swift Laboratories Revenue
Ind-Swift Laboratories had revenue of 86.65M INR in the quarter ending December 31, 2024, a decrease of -96.99%. This brings the company's revenue in the last twelve months to 4.63B, down -61.39% year-over-year. In the fiscal year ending March 31, 2024, Ind-Swift Laboratories had annual revenue of 12.97B with 6.69% growth.
Revenue (ttm)
4.63B
Revenue Growth
-61.39%
P/S Ratio
1.36
Revenue / Employee
98.61M
Employees
47
Market Cap
6.30B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Glenmark Pharmaceuticals | 134.35B |